Stay updated on Dupilumab for AKC: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.

Latest updates to the Dupilumab for AKC: Efficacy Study Clinical Trial page
- Check7 days agoChange DetectedAn NIH website-transition announcement banner was removed from the top of the page. The underlying page remains a 403 Forbidden error.SummaryDifference1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The clinical trial record itself is still not displayed.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, with a Home link and standard header indicating an access restriction.SummaryDifference18%

Stay in the know with updates to Dupilumab for AKC: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.